Ads
related to: best hospital for prostate treatment for womenconsumereview.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Moore has been among a group of researchers spread across six hospitals who have been investigating high-intensity focused ultrasound (HIFU) as a treatment for prostate cancer. Five years after treatment with HIFU the cancer survival rate is 100%, the same as for the more traditional methods of surgery and radiotherapy, but with fewer side-effects.
The hospital is also listed as the best hospital in the Central New Jersey area. [21] In 2007 the hospital was ranked nationally in four specialties by the 2007-08 U.S. News & World Report: Best Hospital rankings. The hospital was ranked #40 in geriatrics, #26 in cardiology & heart surgery, #26 in respiratory disorders, and #50 in urology. [22]
Walsh has been awarded numerous national and international honors. He has co-authored more than 600 articles and three books, including The Prostate: A Guide for Men and the Women Who Love Them. He was the editor-in-chief of Campbell's Textbook of Urology, and for his contributions the book was renamed in his honor. [6]
For prostate cancer, the best treatment often depends on the risk level presented by the disease. For most prostate cancers classified as "very low risk" and "low risk", radical prostatectomy is one of several treatment options; others include radiation, watchful waiting, and active surveillance.
The type of complications depend on the treatment modality used: Urinary incontinence can happen after prostate surgery, especially stress urinary incontinence. The prostate is located right beneath the bladder, and surrounds the urethral sphincter. Any damage to the sphincter or surrounding muscles and nerves can lead to urinary incontinence.
Radiation therapy is commonly used in prostate cancer treatment. It may be used instead of surgery or after surgery in early-stage prostate cancer (adjuvant radiotherapy). Radiation treatments also can be combined with hormonal therapy for intermediate risk disease, when surgery or radiation therapy alone is less likely to cure the cancer.